Ocular involvement (conjunctivitis/scleritis) as a form of presentation in ER-IgG4 in pediatric age
Abstract
IgG4 related disease (ER-IgG4) in pediatric age has manifestations that differ from the ones of adults. There are only case reports and some systematic reviews in the literature. Furthermore, ocular involvement in this population (EOR-IgG4), although common in children, continues to be poorly defined due to the rarity of the disease and the lack of suspicion of it, which leads to a late diagnosis. The clinical case of a 12-year-old patient with EOR-IgG4 with a diagnostic delay of 4 years is described. She presented conjunctivitis, scleritis, ptosis, edema and ocular pain, unilaterally, without extra-ophthalmic involvement. Increased IgG4 and serum IgG4/IgG ratio, involvement of the central belly of the left internal rectus muscle and involvement of the eyelid on images. The pathology anatomy sample showed a lymphoplasmacytic infiltrate, with immunohistochemistry compatible with ER-IgG4. We highlight the importance of pediatric doctors taking this disease into account and knowing its different forms of presentation in this population.References
I. Lu H, Teng F, Zhang P, et al. Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patients. Rheumatology 2021;60:2635-2646. doi:10.1093/rheumatology/keaa651.
II. Griepentrog GJ, Vickers RW, Karesh JW, et al. A clinicopathologic case study of two patients with pediatric orbital IgG4-related disease. Orbit 2013;32:389-391.
III. Kalapesi FB, Garrott HM, Moldovan C, et al. IgG4 orbital inflammation in a 5-year-old child presenting as an orbital mass. Orbit 2013;32:137-140.
IV. Sane M, Chelnis J, Kozielski R, et al. Immunoglobulin G4-related sclerosing disease with orbital inflammation in a 12-year-old girl. JAAPOS 2013; 17:548-550.
V. Smerla R G, Rontogianni D, Fragoulis G E. Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report. Clinical Rheumatology 2018;37:1721-1727.
VI. Qi SR, Hébert M, You E, et al. Conjunctival infiltration in a child as a rare manifestation of IgG4-related disease. Cornea 2022;41:496-498.
VII. Li A, Plesec TP, Mileti L, et al. Isolated Conjunctival inflammation as a manifestation of IgG4-related disease. Cornea 2018;0:1-3.
VIII. Li J, Liu R, Ren T, et al. A case of IgG4-positive ligneous conjunctivitis mistaken for a conjunctival mass. Diagnostic Pathology 2023;18:77.
IX. Chiang WY, Liu TT, Huang WT, et al. Co-existing ligneous conjunctivitis and IgG4-related disease. Indian J Ophthalmol 2016 Jul;64(7):532-534.
X. Umehara H, Okazaki K, Kawa S, et al. Research program for intractable disease by the Ministry of Health, Labor and Welfare (MHLW) Japan. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 2021 May;31(3):529-533.
XI. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 2020 Jan;79(1):77-87.
XII. Hara S, Yoshida M, Sanada H, et al (2024). Pediatric IgG4-related disease: a descriptive review. Expert Review of Clinical Immunology 2024;97-119.
XIII. Karim F, Loeffen J, Bramer W, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatric Rheumatology 2016;14:1-9.
XIV. de Sainte Marie B, Ebbo M, Grados A, et al. A descriptive study of IgG4-related disease in children and young adults. Autoimmunity reviews 2022;21(4):103035.
XV. Kaya Akca Ü, Atalay E, Kasap Cüceoğlu M, et al. IgG4-related disease in pediatric patients: a single-center experience. Rheumatology international 2022;42(7):1177-1185.
Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Society of Rheumatology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
